The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early results from a phase 1, multicenter trial of PSCA-specific GoCAR T cells (BPX-601) in patients with metastatic castration-resistant prostate cancer (mCRPC).
 
Mark N. Stein
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex; Exelixis; Exelixis; Janssen Oncology; Merck Sharp & Dohme; Vaccitech; Xencor
Research Funding - Advaxis (Inst); Bellicum Pharmaceuticals; Bristol-Myers Squibb (Inst); Exelixis (Inst); Genocea Biosciences (Inst); Harpoon (Inst); Janssen Oncology (Inst); Lilly (Inst); Medivation/Astellas (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Oncoceutics (Inst); Seagen (Inst); Suzhou Kintor Pharmaceuticals (Inst); Tmunity Therapeutics, Inc. (Inst); Xencor (Inst)
 
Benjamin A. Teply
Consulting or Advisory Role - AstraZeneca; Hospicom; Lilly; Pfizer/Myovant; Sanofi; Seagen
Research Funding - Bellicum Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); QED Therapeutics (Inst)
 
Usama Gergis
Stock and Other Ownership Interests - Apellis Pharmaceuticals; Gamida Cell; Iovance Biotherapeutics; Moderna Therapeutics; Omeros
Honoraria - Astellas Pharma; Gamida Cell; Incyte; Jazz Pharmaceuticals; Kite, a Gilead company; Mesoblast
Consulting or Advisory Role - Gamida Cell; Jazz Pharmaceuticals; mesoblast
Speakers' Bureau - Astellas Pharma; Incyte; Jazz Pharmaceuticals; Kite, a Gilead company
Travel, Accommodations, Expenses - Incyte; Jazz Pharmaceuticals
 
Donald Strickland
Employment - Bellicum Pharmaceuticals
Leadership - Day One Biopharmaceuticals (I)
 
Joseph Senesac
Employment - Bellicum Pharmaceuticals
Leadership - Bellicum Pharmaceuticals
Stock and Other Ownership Interests - Bellicum Pharmaceuticals
 
Henri Bayle
Employment - Bellicum Pharmaceuticals; NKILT Therapeutics
Leadership - Bellicum Pharmaceuticals; NKILT Therapeutics
Stock and Other Ownership Interests - Bellicum Pharmaceuticals; Bluebird Bio; Medicenna; Merck; NKILT Therapeutics; Poseida Therapeutics
Patents, Royalties, Other Intellectual Property - Patents and patents pending with Bellicum Pharmaceuticals. Assigned to Bellicum; Patents pending with NKILT Therapeutics. Assigned to NKILT.
 
Monica Sheila Chatwal
Speakers' Bureau - Merck
 
Mehmet Asim Bilen
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Exelixis; Genomic Health; Janssen; Nektar; Pfizer; Sanofi; Seagen
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech/Roche (Inst); Genome & Company (Inst); Incyte (Inst); Merck (Inst); Nektar (Inst); NiKang Therapeutics (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Tricon Pharmaceuticals (Inst); Xencor (Inst)
 
Walter Michael Stadler
Leadership - EMA Wellness
Consulting or Advisory Role - AstraZeneca; Bayer; Calico; CVS Caremark; Eisai; Merck; Pfizer; Treadwell Therapeutics
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Medivation (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Clovis Oncology (Inst); Corvus Pharmaceuticals (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Johnson & Johnson (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Seagen (I); Tesaro (Inst); X4 Pharma (Inst)
Expert Testimony - Teva
Other Relationship - American Cancer Society; UpToDate
 
Ecaterina Elena Dumbrava
Consulting or Advisory Role - Bolt Biotherapeutics
Research Funding - Aileron Therapeutics (Inst); Amgen (Inst); Aprea Therapeutics (Inst); Astex Pharmaceuticals (Inst); Bayer (Inst); Bellicum Pharmaceuticals (Inst); Bolt Biotherapeutics (Inst); Compugen (Inst); Gateway Foundation (Inst); Immunocore (Inst); Immunomedics/Gilead (Inst); Mereo BioPharma 5 (Inst); PMV Pharma (Inst); Rain Therapeutics (Inst); Sanofi (Inst); Seagen (Inst); TRACON Pharma (Inst); Triumvira Immunologics, Inc (Inst); Unum Therapeutics (Inst)